Related Experiment Video
Updated: Mar 25, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
12.2K
Osteoporosis: A Silent Disease with Complex Genetic Contribution
Maryam Mafi Golchin1, Laleh Heidari2, Seyyed Mohammad Hossein Ghaderian2
1Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol 4717647745, Iran.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|March 1, 2016
Summary
Osteoporosis, a common bone disorder, has a significant genetic basis. Understanding osteoporosis susceptibility genes and genetic markers like single nucleotide polymorphisms (SNPs) aids in identifying at-risk individuals for prevention and targeted therapies.
Area of Science:
- Genetics
- Metabolic Bone Diseases
- Osteoporosis Research
Background:
- Osteoporosis is a prevalent multifactorial metabolic bone disorder with a substantial genetic influence.
- Identifying genetic factors is crucial for understanding disease etiology and variability.
Purpose of the Study:
- To review the evidence for genetic contributions to osteoporosis and related phenotypes.
- To discuss methods for identifying osteoporosis susceptibility genes and key biological pathways.
- To present single nucleotide polymorphisms (SNPs) as genetic markers for osteoporosis.
Main Methods:
- Literature review of genetic studies in osteoporosis.
- Analysis of genetic association studies and meta-analyses.
- Examination of next-generation sequencing data for genetic insights.
Main Results:
- A strong genetic component underlies osteoporosis and its related phenotypes.
- Key genes and biological pathways involved in bone development have been identified.
- Specific single nucleotide polymorphisms (SNPs) are significant genetic markers for osteoporosis risk.
Conclusions:
- Next-generation sequencing and meta-analyses enhance understanding of osteoporosis genetics.
- Genetic insights can lead to improved identification of at-risk patients.
- This knowledge supports personalized prevention strategies and novel therapeutic targets for osteoporosis.
Related Concept Videos
01:29Bone Disorders
7.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.0K
01:28Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
108
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
01:27Principles of Pharmacogenetics: Types of Genetic Variants
87
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
87
01:17Hormones and Bone Tissue
4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
01:40Bone Remodeling
41.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.0K